Citigroup Operating Cash Flow increased by 40.2% to -$21.87B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 62.7%, from -$58.71B to -$21.87B. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $365.00M | $35.62B | -$9.25B | $23.49B | $0.00 | $12.81B | -$30.49B | -$54.06B | -$4.67B | -$10.83B | -$16.96B | -$16.67B | -$58.71B | -$36.58B | -$21.87B |
| QoQ Change | — | >999% | -126.0% | +354.0% | -100.0% | — | -337.9% | -77.3% | +91.4% | -132.1% | -56.6% | +1.7% | -252.1% | +37.7% | +40.2% |
| YoY Change | — | — | — | >999% | -100.0% | — | -229.7% | -330.1% | -136.4% | +64.5% | +68.6% | — | -442.0% | -115.7% | +62.7% |